ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FAB Fusion Antibodies Plc

3.40
0.00 (0.00%)
07 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Fusion Antibodies Plc LSE:FAB London Ordinary Share GB00BDQZGK16 ORD 4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 3.40 3.30 3.50 3.40 3.40 3.40 194,648 07:40:36
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 2.9M -2.6M -0.0272 -1.25 3.24M
Fusion Antibodies Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker FAB. The last closing price for Fusion Antibodies was 3.40p. Over the last year, Fusion Antibodies shares have traded in a share price range of 3.10p to 9.875p.

Fusion Antibodies currently has 95,365,564 shares in issue. The market capitalisation of Fusion Antibodies is £3.24 million. Fusion Antibodies has a price to earnings ratio (PE ratio) of -1.25.

Fusion Antibodies Share Discussion Threads

Showing 201 to 223 of 4100 messages
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older
DateSubjectAuthorDiscuss
22/7/2020
11:56
Turned a hint of blue -
tomboyb
22/7/2020
09:12
none at these levels anyway -
tomboyb
22/7/2020
08:40
So basically there's no stock around at all.
thejaba
22/7/2020
08:36
Your broker is better than mine -

I'm getting 125 shares at 95p -

tomboyb
22/7/2020
08:23
Something definitely going on....you can only buy 150 shares at 95p. Anything more is NT.
thejaba
22/7/2020
08:06
Morning -

nothing at 95p -

tomboyb
21/7/2020
19:06
Good evening -

Virtually no stock available at days end at 95p, in fact most of today -

Lets see where we are tomorrow -

tomboyb
21/7/2020
15:09
no stock at all at 93p.
tomboyb
21/7/2020
12:37
fab rise today
also heads up ,webinar tomorrow ncyt ,is rns going to be released there today / tomorrow

bunz3
21/7/2020
12:32
My broker online has 15 shares available at 90p -
tomboyb
21/7/2020
12:14
Can anyone buy? -
tomboyb
15/7/2020
20:57
AstraZeneca jumps 7% ahead of COVID-19 vaccine update https://seekingalpha.com/news/3591485-astrazeneca-jumps-7-ahead-of-covidminus-19-vaccine-update
fhasson
06/7/2020
21:38
Trying to discern what’s so negative about this update to justify today’s share price fall
cbeadle
16/6/2020
10:35
As fears over the pandemic have lifted to an extent, certain companies' share prices have fallen back somewhat.With many experts predicting a second wave, these companies' could quickly come back into fashion...#ODX #FAB #SNG #NCYT #ORPH #AVCT #WSGhttps://total-market-solutions.com/2020/06/16/covid-19-updated/
burtond1
14/6/2020
13:04
FAB Research Note Part 2
maverick247
06/6/2020
18:19
Long article in Daily Mail on Antibodies.
vivgav
21/5/2020
21:09
https://docs.google.com/document/d/1IvYHzLa_pdLNGQzRdhVIas6XtCpW5ATEEudQt9Je3fk/mobilebasic
maverick247
20/5/2020
14:09
If Doc likes it expect funding to come your way. Dr Bucket shop.
tidy 2
20/5/2020
08:36
Here, @DDS_DocHoliday caught up with @FsnAntibodies CFO James Fair to learn more about the business and who they are.#FAB offers a complete range of antibody-related services in Discovery, Engineering, and Supply...https://twitter.com/tmsreach/status/1263009722334097408?s=21
burtond1
18/5/2020
11:08
Held back by the recent fundraising but hopefully now they will start going forward
cbeadle
12/5/2020
16:01
That was a lot of info packed into 13 minutes. Let’s hope the confidence translates into a working therapeutic antibody to help fight Covid-19.
gwr7
12/5/2020
13:21
Proactive Investor 12/5/20

Fusion Antibodies PLCFusion Antibodies CEO sees 'enormous value' in discovery platform as it expands to include COVID-19

Fusion Antibodies PLC (LON:FAB) CEO Paul Kerr speaks to Proactive London's Andrew Scott following their oversubscribed £3mln fundraise.

He says they now have the resources to carry out additional proof-of-concept work on their Mammalian Antibody Library Discovery Platform, which has been expanded to include COVID-19, as well as for their existing oncology targets.

moneymunch
12/5/2020
13:17
This should start moving big time with the first tranche of placing shares admitted tomorrow followed by the AGM on Friday for shareholder approval for the next batch for the following week, and of course news/update could drop at anytime thereafter....only 26m shares is issue following the placing, and so could be highly sort after on good news, especially Covid-19 related. Gla :-)
moneymunch
Chat Pages: Latest  20  19  18  17  16  15  14  13  12  11  10  9  Older